Efficacy Study of Minoxidil Lotion Versus Combined Minoxidil and Finasteride Lotion to Treat Male Pattern Hair Loss
Information source: Mae Fah Luang University Hospital
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Androgenetic Alopecia
Intervention: 3%Minoxidil lotion (Drug); 3% Minoxidil with 0.1% Finasteride lotion (Drug)
Phase: Phase 3
Status: Completed
Sponsored by: Mae Fah Luang University Hospital Official(s) and/or principal investigator(s): Chuchai Tanglertsampan, MD, Principal Investigator, Affiliation: Mae Fah Luang University Hospital(Bangkok)
Summary
The purpose of this study is to compare the efficacy of 3% Minoxidil lotion and 3% Minoxidil
with 0. 1% Finasteride lotion for 6 months in male pattern hair loss.
Clinical Details
Official title: Efficacy of 3% Minoxidil Versus Combined 3% Minoxidil and 0.1% Finasteride for Male Pattern Hair Loss: a Randomized, Double-blinded, Comparative Study
Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Primary outcome: The mean change of hair count from baseline and 6 months
Secondary outcome: Global photographic assessment by dermatologists
Eligibility
Minimum age: 18 Years.
Maximum age: 50 Years.
Gender(s): Male.
Criteria:
Inclusion Criteria:
- male, age 18-15 years
- androgenetic alopecia grade 3V to 5 ( Norwood-Hamilton classification)
Exclusion Criteria:
- use minoxidil in 6 months
- use finasteride in 12 months
- use ketoconazole, tar, selenium shampoo, topical tretinoin, topical steroid in 2
weeks
- seborrheic dermatitis or psoriasis on scalp
- history of allergy to minoxidil, finasteride
Locations and Contacts
Mae Fah Luang University Hospital(Bangkok), Bangkok, Thailand
Additional Information
Starting date: March 2011
Last updated: July 19, 2012
|